Jennifer L. Lund, PhD
Jennifer L. Lund, PhD
Her geriatric oncology research addresses: 1) the quality of cancer care, 2) the effectiveness and safety of cancer treatments and 3) the role of polypharmacy, multimorbidity, and frailty in cancer treatment selection and outcomes.
Dr. Lund has worked extensively with the Surveillance, Epidemiology and End Results program (SEER) Medicare data to examine patterns of chemotherapy uptake and investigate multilevel factors associated with the dissemination of innovative treatments among older cancer patients. She also has amassed international experience using large linked databases in Canada and Denmark.
Honors and AwardsYoung Investigator Award Finalist
2019, International Society for Geriatric OncologyGordon H. DeFriese Career Development in Aging Research Award
2015, Institute on Aging, University of North Carolina at Chapel HillAbstract Achievement Award
2013, American Society of Hematology
EPID 766: Epidemiologic Research Using Healthcare Databases | Syllabus
This course teaches students how to use administrative healthcare utilization data for epidemiologic studies.
Health services research
Comparative effectiveness and safety research
Geriatric oncology research
Member, PhD Admissions Committee, Department of Epidemiology (2019-present)
Member, Graduate Studies Committee, Department of Epidemiology (2014-2018)
Data linkage in pharmacoepidemiology: A call for rigorous evaluation and reporting. Pratt NL, Mack CD, Meyer AM, Davis KJ, Hamill BG, Hampp C, Setoguchi S, Raman SR, Chun DS, Sturmer T, Lund JL (2019). Pharmacoepidemiology and Drug Safety.
Development and validation of a five-year mortality prediction model using machine learning and Medicare data. Lund JL, Kuo M, Brookhart MA, Meyer AM, Dalton AF, Kistler CE, Wheeler SB, Lewis CL (2019). Pharmacoepidemiology and Drug Safety, 28(5), 584-592.
Comparison of Medicare claims-based measures of poor physical function and associations with treatment receipt and mortality in older colon cancer patients. Mayer SE, Tan HJ, Hinton SP, Sanoff HK, Stürmer T, Hester LL, Faurot KR, Funk MJ, Lund JL (2019). Medical Care, 57(4), 286-294.
Diagnostic assessment of transportability of intervention effects from a randomized trial to a routine care population: An application to metastatic colorectal cancer. Webster-Clark MA, Sanoff HK, Stürmer T, Hinton SP, Lund JL (2019). Epidemiology, 30(1), 103-111.
Potential Medication-Related Problems in Older Breast, Colon, and Lung Cancer Patients in the United States. Lund JL, Sanoff HK, Hinton SP, Muss HB, Pate V, Stürmer T (2018). Cancer Epidemiol Biomarkers Prev, 27(1), 41-49.
Data Linkage to Improve Geriatric Oncology Research: A Feasibility Study. Lund JL, Meyer AM, Deal AM, Choi BJ, Chang YK, Williams GR, Pergolotti M, Guerard EJ, Muss HB, Sanoff HK (2017). The Oncologist, 22(8), 1002-1005.
BA, Quantitative Economics/International Relations, Tufts University, 2003
MSPH, Epidemiology, The University of North Carolina at Chapel Hill, 2009
PhD, Epidemiology, The University of North Carolina at Chapel Hill, 2011